ALPHA TEKNOVA, INC. Cost of Revenue
ALPHA TEKNOVA, INC. (TKNO) reported Cost of Revenue of $7.30 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- ALPHA TEKNOVA, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $7.30M, a 15.82% increase year-over-year.
- ALPHA TEKNOVA, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $7.29M, a 7.44% increase year-over-year.
- ALPHA TEKNOVA, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $6.74M, a 5.56% decline year-over-year.
- ALPHA TEKNOVA, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $7.25M, a 23.59% decline year-over-year.
- ALPHA TEKNOVA, INC. cost of goods and services sold for fiscal 2025 was $27.08M, a 11.26% decline from fiscal 2024.
- ALPHA TEKNOVA, INC. cost of goods and services sold for fiscal 2024 was $30.51M, a 15.64% increase from fiscal 2023.
- ALPHA TEKNOVA, INC. cost of goods and services sold for fiscal 2023 was $26.39M, a 10.21% increase from fiscal 2022.
- ALPHA TEKNOVA, INC. cost of goods and services sold for fiscal 2022 was $23.94M, a 24.24% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.30M 10-Q · filed 2026-08-06 | $14.59M 10-Q · filed 2026-08-06 | $21.33M derived: sum of 3 quarters · filed 2026-08-06 | $28.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $7.29M 10-Q · filed 2026-05-07 | $14.03M derived: sum of 2 quarters · filed 2026-05-07 | $21.28M derived: sum of 3 quarters · filed 2026-05-07 | $27.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $6.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $13.99M derived: sum of 2 quarters · filed 2026-03-02 | $20.29M derived: sum of 3 quarters · filed 2026-08-06 | $27.08M 10-K · filed 2026-03-02 |
| 2025-09-30 | $7.25M 10-Q · filed 2025-11-07 | $13.55M derived: sum of 2 quarters · filed 2026-08-06 | $20.34M 10-Q · filed 2025-11-07 | $27.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $6.30M 10-Q · filed 2026-08-06 | $13.09M 10-Q · filed 2026-08-06 | $20.23M derived: sum of 3 quarters · filed 2026-08-06 | $29.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $6.79M 10-Q · filed 2026-05-07 | $13.93M derived: sum of 2 quarters · filed 2026-05-07 | $23.41M derived: sum of 3 quarters · filed 2026-05-07 | $30.22M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $7.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $16.62M derived: sum of 2 quarters · filed 2026-03-02 | $23.43M derived: sum of 3 quarters · filed 2026-03-02 | $30.51M 10-K · filed 2026-03-02 |
| 2024-09-30 | $9.49M 10-Q · filed 2025-11-07 | $16.30M derived: sum of 2 quarters · filed 2025-11-07 | $23.38M 10-Q · filed 2025-11-07 | $29.91M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $6.81M 10-Q · filed 2025-08-08 | $13.89M 10-Q · filed 2025-08-08 | $20.42M derived: sum of 3 quarters · filed 2025-08-08 | $27.12M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $7.08M 10-Q · filed 2025-05-09 | $13.61M derived: sum of 2 quarters · filed 2025-05-09 | $20.31M derived: sum of 3 quarters · filed 2025-05-09 | $26.77M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $6.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $13.23M derived: sum of 2 quarters · filed 2025-03-07 | $19.69M derived: sum of 3 quarters · filed 2025-03-07 | $26.39M 10-K · filed 2025-03-07 |
| 2023-09-30 | $6.70M 10-Q · filed 2024-11-08 | $13.16M derived: sum of 2 quarters · filed 2024-11-08 | $19.86M 10-Q · filed 2024-11-08 | $25.64M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $6.46M 10-Q · filed 2024-08-13 | $13.16M 10-Q · filed 2024-08-13 | $18.94M derived: sum of 3 quarters · filed 2024-08-13 | $24.86M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $6.70M 10-Q · filed 2024-05-13 | $12.48M derived: sum of 2 quarters · filed 2024-05-13 | $18.40M derived: sum of 3 quarters · filed 2024-05-13 | $24.84M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $11.70M derived: sum of 2 quarters · filed 2024-03-27 | $18.15M derived: sum of 3 quarters · filed 2024-03-27 | $23.94M 10-K · filed 2024-03-27 |
| 2022-09-30 | $5.92M 10-Q · filed 2023-11-13 | $12.37M derived: sum of 2 quarters · filed 2023-11-13 | $18.16M 10-Q · filed 2023-11-13 | $23.29M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $6.44M 10-Q · filed 2023-08-11 | $12.24M 10-Q · filed 2023-08-11 | $17.37M derived: sum of 3 quarters · filed 2023-08-11 | $22.50M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $5.80M 10-Q · filed 2023-05-11 | $10.93M derived: sum of 2 quarters · filed 2023-05-11 | $16.06M derived: sum of 3 quarters · filed 2023-05-11 | $21.02M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $5.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $10.26M derived: sum of 2 quarters · filed 2023-03-30 | $15.22M derived: sum of 3 quarters · filed 2023-03-30 | $19.27M 10-K · filed 2023-03-30 |
| 2021-09-30 | $5.13M 10-Q · filed 2022-11-14 | $10.09M derived: sum of 2 quarters · filed 2022-11-14 | $14.14M 10-Q · filed 2022-11-14 | $18.73M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $4.96M 10-Q · filed 2022-08-11 | $9.01M 10-Q · filed 2022-08-11 | $13.60M derived: sum of 3 quarters · filed 2022-08-11 | $17.50M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $4.05M 10-Q · filed 2022-05-12 | $8.64M derived: sum of 2 quarters · filed 2022-05-12 | $12.54M derived: sum of 3 quarters · filed 2022-05-12 | $15.11M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $8.48M derived: sum of 2 quarters · filed 2022-03-18 | $11.06M derived: sum of 3 quarters · filed 2022-03-18 | $13.54M 10-K · filed 2022-03-18 |
| 2020-09-30 | $3.90M 10-Q · filed 2021-11-12 | $6.47M derived: sum of 2 quarters · filed 2021-11-12 | $8.95M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $2.58M 10-Q · filed 2021-08-13 | $5.06M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |